Clinical Trial Update: A Study Of Mircera In Patients With Kidney Disease Who Are Not On Dialysis

View source ↗

Summary

The clinical trial evaluating Mircera in non-dialysis kidney disease patients with distal renal tubular acidosis and hemolytic anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Tubular Acidosis Distal with Hemolytic Anemia

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Renal Tubular Acidosis, Distal, With Hemolytic Anemia | Status: COMPLETED